COR

#191
Cencora, Inc.
372.0700
+1.55%
Sector:
Base:
Profit Currency:
Daily Range
369.9300
374.0400
Year Range
328.0100
377.5300
Daily Change
+1.55%
Monthly Change
+4.58%
6 month change
+12.40%
Year Change
+12.40%
Previous Close
366.3850
Open
369.9300
Bid
Ask
Low
369.9300
High
374.0400
Volume
1 212
Open full chart

Financials

Overview Statement Statistics Dividends
Quarterly Annual
  • Market Capitalization 72.2631 B
  • Employee 51 K
  • Founded N/A
  • CEO Steven H. Collis
  • Website www.cencora.com
  • Headquarter Delaware, United States
  • FIGI BBG000MDCQC2
  • Industry Technology
Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
Price to earnings ratio
40.55
Price to sales ratio
0.2
Dividends per share
0.6
Dividend yield %
1.64

Cencora Inc

Cencora, Inc., formerly known as AmerisourceBergen, is an American drug wholesale and distribution company and a contract research organization, that was formed by the merger of Bergen Brunswig and AmeriSource in 2001. It was renamed to Cencora in 2023. Cencora is one of the largest pharmaceutical companies in the world and distributes generic pharmaceuticals, over-the-counter healthcare products, as well as home healthcare supplies and equipment.

News